98 related articles for article (PubMed ID: 1667951)
21. [Significance of soluble thrombomodulin in the coronary circulation of patients with coronary artery disease].
Nakagawa I; Matsubara T; Hori T; Imai S; Ozaki K; Mezaki T; Nasuno A; Kubota K; Nakano M; Yamazoe M; Aizawa Y
J Cardiol; 2001 Sep; 38(3):145-52. PubMed ID: 11577611
[TBL] [Abstract][Full Text] [Related]
22. Circulating thrombomodulin during radiation therapy of lung cancer.
Hauer-Jensen M; Kong FM; Fink LM; Anscher MS
Radiat Oncol Investig; 1999; 7(4):238-42. PubMed ID: 10492164
[TBL] [Abstract][Full Text] [Related]
23. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
24. Plasma thrombomodulin: new approach of endothelium damage.
Seigneur M; Dufourcq P; Conri C; Constans J; Mercie P; Pruvost A; Boisseau M
Int Angiol; 1993 Dec; 12(4):355-9. PubMed ID: 8207313
[TBL] [Abstract][Full Text] [Related]
25. Soluble markers of endothelial cell function.
Blann A; Seigneur M
Clin Hemorheol Microcirc; 1997; 17(1):3-11. PubMed ID: 9181753
[TBL] [Abstract][Full Text] [Related]
26. [Molecular markers of hemostatic mechanisms--clinical significance of the measurement of plasma thrombomodulin].
Ishii H; Uchiyama H; Hiraishi S; Nakano M; Tsubouchi J; Kazama M; Tanaka A
Rinsho Byori; 1989 Mar; 37(3):266-71. PubMed ID: 2545950
[No Abstract] [Full Text] [Related]
27. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Nadar SK; Al Yemeni E; Blann AD; Lip GY
Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
[TBL] [Abstract][Full Text] [Related]
28. Increased plasma thrombomodulin in cancer patients.
Lindahl AK; Boffa MC; Abildgaard U
Thromb Haemost; 1993 Feb; 69(2):112-4. PubMed ID: 8384380
[TBL] [Abstract][Full Text] [Related]
29. Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation.
Skrabal CA; Choi YH; Kaminski A; Steiner M; Kundt G; Steinhoff G; Liebold A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):291-6. PubMed ID: 16872952
[TBL] [Abstract][Full Text] [Related]
30. [Histochemical observation using thrombomodulin staining method for damage of sinusoidal endothelial cells: preliminary report].
Ueno S; Kobayashi Y; Mitsue S; Tanabe G; Aiko T; Shimazu H
Nihon Geka Gakkai Zasshi; 1993 May; 94(5):538. PubMed ID: 7687322
[No Abstract] [Full Text] [Related]
31. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis.
Neidhart M; Wehrli R; Brühlmann P; Michel BA; Gay RE; Gay S
Arthritis Rheum; 1999 Apr; 42(4):622-30. PubMed ID: 10211875
[TBL] [Abstract][Full Text] [Related]
32. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
Wu KK; Matijevic-Aleksic N
Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
[TBL] [Abstract][Full Text] [Related]
33. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
[TBL] [Abstract][Full Text] [Related]
34. [Soluble thrombomodulin--a molecular marker of endothelial cell injury in children and adolescents with obesity].
Urban M; Wojtkielewicz K; Głowińska B; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):73-7. PubMed ID: 15996335
[TBL] [Abstract][Full Text] [Related]
35. Thrombin downregulates thrombomodulin expression and activity in primary human endothelial cells.
Séguin C; Abid MR; Spokes KC; Aird WC
Endothelium; 2008; 15(3):143-8. PubMed ID: 18568955
[TBL] [Abstract][Full Text] [Related]
36. Relationship between soluble thrombomodulin in patients with intermittent claudication and critical ischemia.
Nasser M; Wolosker N; Uint L; Rosoky RA; Lobato M; Wajngarten M; Puech-Leao P
Thromb Res; 2006; 117(3):271-7. PubMed ID: 15890390
[TBL] [Abstract][Full Text] [Related]
37. Venous occlusion does not induce the release of thrombomodulin from endothelial cells in patients with thromboembolic disease.
Alessi MC; Boffa MC; Menart C; Aillaud MF; Parrot G; Juhan-Vague I
Thromb Haemost; 1992 Oct; 68(4):483-4. PubMed ID: 1333102
[No Abstract] [Full Text] [Related]
38. DDAVP does not induce the release of thrombomodulin from endothelial cells.
Takahashi H; Tatewaki W; Wada K; Niwano H; Hanano M; Tsubouchi J; Nagai T; Shibata A
Thromb Haemost; 1991 Apr; 65(4):451. PubMed ID: 1647554
[No Abstract] [Full Text] [Related]
39. Increase in plasma thrombomodulin and decrease in plasma von Willebrand factor after regular radiotherapy of patients with cancer.
Zhou QS; Zhao YM; Xu CS; Yu ZY; Yao DY; Gao YM; Ruan CG
Thromb Res; 1992 Oct; 68(2):109-18. PubMed ID: 1335614
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of thrombomodulin analysis in blood coagulo-fibrinolytic tests].
Sakuragawa N
Nihon Rinsho; 1989 Dec; 48 Suppl():881-4. PubMed ID: 2560081
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
